A long-term, open-label, safety extension study of the combination of Fenofibric Acid and statin therapy for subjects with mixed dyslipidemia

Trial Profile

A long-term, open-label, safety extension study of the combination of Fenofibric Acid and statin therapy for subjects with mixed dyslipidemia

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jul 2009

At a glance

  • Drugs Atorvastatin; Choline fenofibrate; Rosuvastatin; Simvastatin
  • Indications Dyslipidaemias
  • Focus Adverse reactions; Registrational
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Jul 2009 Actual patient number (1911) added as reported by ClinicalTrials.gov.
    • 12 Jun 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top